Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis

Bioorganic & Medicinal Chemistry Letters - Tập 14 - Trang 3595-3599 - 2004
Laszlo Revesz1, Ernst Blum1, Franco E. Di Padova1, Thomas Buhl1, Roland Feifel1, Hermann Gram1, Peter Hiestand1, Ute Manning1, Gerard Rucklin1
1Novartis Institutes for BioMedical Research, Arthritis & Bone Metabolism, CH-4002 Basel, Switzerland

Tài liệu tham khảo

Chakravarty, 2002, Annu. Rep. Med. Chem., 37, 177, 10.1016/S0065-7743(02)37019-2 Revesz, 2000, Bioorg. Med. Chem. Lett., 10, 1261, 10.1016/S0960-894X(00)00200-6 Wang, 1998, Structure, 6, 1117, 10.1016/S0969-2126(98)00113-0 Revesz, L. WO 0130778; Chem. Abstr. 2001, 134, 340507 Revesz, L.; Schlapbach, A. WO 0063204; Chem. Abstr. 2000, 133, 321897 Von Bebenburg, 1979, Chemiker-Zeitung, 103, 387 Majeed, 1989, Tetrahedron, 45, 993, 10.1016/0040-4020(89)80011-0 Revesz, 2002, Bioorg. Med. Chem. Lett., 12, 2109, 10.1016/S0960-894X(02)00336-0